BioSpace News Archive

Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, announces the presentation of preclinical data at the 59th Congress of the European Renal Association (ERA), the largest annual nephrology meeting in Europe, currently held in Paris, France.

Connecticut-based medical device innovator Lumendi, LLC has announced it has filed for U.S. Food and Drug Administration 510 clearance for DiLumen EZ¹, a single-use, disposable endotherapy device intended for endoscopic mucosal resections and difficult colonoscopies.

Healthcare chatbots are computer programs that help patients with their medical and related queries.

Evotec SE and Almirall S.A., a global biopharmaceutical company focused on skin health, announced a multi-target alliance in Medical Dermatology.

Albany NY, United States: The global medical holography market features an extremely competitive market landscape with numerous market players focusing on the development of new products, reports Transparency Market Research.

Albany NY, United States: Transparency Market Research has published a new report titled ‘Intracranial Stents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the intracranial stents market was valued at US$ 298.7 Mn in 2017.

Albany NY, United States: The demand within the global hormonal contraceptives market is rising at a stellar pace in recent times.

Albany NY, United States: The global vascular graft market was valued at US$ 2.6 Bn in 2021 and is projected to expand at a CAGR of 5.3% from 2022 to 2031.

The annual London Calling genomics conference, hosted by Oxford Nanopore, starts , featuring more than 80 scientific talks across a range of disciplines, with thousands of scientists expected to attend either in person or online.

Brainlab announced that clinicians at UZ Brussel are the first to treat patients with the company’s new Deep Inspiration Breath Hold technology designed to streamline image guided and surface guided radiation therapy and deliver the highest quality of care for breast cancer patients.